Pharmacovigilance (Amendment) Regulations, 2013

This procedure concerns amendments to the Pharmacovigilance Regulations of 2013. It aims to update rules for monitoring the safety of medicines and ensuring public health. These changes will affect pharmaceutical companies, healthcare professionals, and patients by potentially altering reporting requirements and safety surveillance measures for medicinal products.